Understanding patient outcomes after acute respiratory distress syndrome: Identifying subtypes of physical, cognitive and mental health outcomes

Thorax

Volumn 72, Issue 12, 2017, Pages 1094-1103

  Brown, Samuel M ^a,b,c   Wilson, Emily L ^a,b   Presson, Angela P ^c   Dinglas, Victor D ^d,e   Greene, Tom ^c   Hopkins, Ramona O ^a,b,f   Needham, Dale M ^d,e  

^a INTERMOUNTAIN HEALTHCARE   (United States)

^b INTERMOUNTAIN MEDICAL CENTER   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

ARDS; health related quality of life; mental health; outcomes; physical function; prediction

Indexed keywords

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; COGNITION; DISEASE SEVERITY; FEMALE; HEALTH STATUS; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PHYSICAL DISABILITY; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; SURVIVOR; ACUTE DISEASE; AGE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED STUDY; EPIDEMIOLOGY; ETHNOLOGY; FOLLOW UP; MIDDLE AGED; MULTICENTER STUDY; PROGNOSIS; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ACUTE DISEASE; ADULT; AGE FACTORS; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HISPANIC AMERICANS; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SMOKING; UNITED STATES;

EID: 85037126039     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2017-210337     Document Type: Article

References (56)

1. Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: The Berlin Definition. JAMA 2012;307:2526-33.
2. Erickson SE, Martin GS, Davis JL, et al. Recent trends in acute lung injury mortality: 1996-2005. Crit Care Med 2009;37:1574-9.
3. Herridge MS, Tansey CM, Matté A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 2011;364:1293-304.
4. Deutschman CS, Ahrens T, Cairns CB, et al. Multisociety Task Force for Critical Care Research: Key issues, recommendations. Crit Care Med 2012;40:254-60.
5. Herridge MS, Cheung AM, Tansey CM, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003;348:683-93.
6. Davydow DS, Desai SV, Needham DM, et al. Psychiatric morbidity in survivors of the acute respiratory distress syndrome: A systematic review. Psychosom Med 2008;70:512-9.
7. Herridge MS, Moss M, Hough CL, et al. Recovery, outcomes after the acute respiratory distress syndrome (ARDS) in patients, their family caregivers. Intensive Care Med 2016;42:725-38.
8. E lliott D, Davidson JE, Harvey MA, et al. Exploring the scope of post-intensive care syndrome therapy, care: Engagement of non-critical care providers, survivors in a second stakeholders meeting. Crit Care Med 2014;42:2518-26.
9. N eedham DM, Davidson J, Cohen H, et al. Improving long-term outcomes after discharge from intensive care unit: Report from a stakeholders' conference. Crit Care Med 2012;40:502-9.
10. G riffiths RD. Rehabilitating the critically ill: A cultural shift in intensive care unit care. Crit Care Med 2012;40:681-2.
11. L ötvall J, Akdis CA, Bacharier LB, et al. Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol 2011;127:355-60.
12. R ussell CD, Baillie JK. Treatable traits, therapeutic targets: Goals for systems biology in infectious disease. Curr Opin Syst Biol 2017;2:140-6.
13. Jameson JL, Longo DL. Precision medicine-personalized, problematic, , promising. N Engl J Med 2015;372:2229-34.
14. Herridge M, Cameron JI. Disability after critical illness. N Engl J Med 2013;369:1367-9.
15. Pearmain L, Herridge MS. Outcomes after ARDS: A distinct group in the spectrum of disability after complex, protracted critical illness. Minerva Anestesiol 2013;79:793-803.
16. Matthay MA, Brower RG, Carson S, et al. Randomized, placebo-controlled clinical trial of an aerosolized-agonist for treatment of acute lung injury. Am J Respir Crit Care Med 2011;184:561-8.
17. R ice TW, Wheeler AP, Thompson BT, et al. Initial trophic vs full enteral feeding in patients with acute lung injury: The EDEN randomized trial. JAMA 2012;307:795-803.
18. R ice TW, Wheeler AP, Thompson BT, et al. Enteral omega-3 fatty acid, gammalinolenic acid, , antioxidant supplementation in acute lung injury. JAMA 2011;306:1574-81.
19. N eedham DM, Dinglas VD, Bienvenu OJ, et al. One year outcomes in patients with acute lung injury randomised to initial trophic or full enteral feeding: Prospective follow-up of EDEN randomised trial. BMJ 2013;346:f1532.
20. N eedham DM, Dinglas VD, Morris PE, et al. Physical, cognitive performance of patients with acute lung injury 1 year after initial trophic versus full enteral feeding. EDEN trial follow-up. Am J Respir Crit Care Med 2013;188:567-76.
21. Dinglas VD, Hopkins RO, Wozniak AW, et al. One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: Prospective followup of SAILS randomised trial. Thorax 2016;71:401-10.
22. Horvath S. Weighted Network analysis: Applications in genomics, Systems Biology: Springer, 2011.
23. E uroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
24. T urnbull AE, Rabiee A, Davis WE, et al. Outcome Measurement in ICU Survivorship Research from 1970 to 2013: A scoping review of 425 Publications. Crit Care Med 2016;44:1267-77.
25. Dowdy DW, Eid MP, Sedrakyan A, et al. Quality of life in adult survivors of critical illness: A systematic review of the literature. Intensive Care Med 2005;31:611-20.
26. Brown SM, Wilson E, Presson AP, et al. Predictors of 6-month health utility outcomes in survivors of acute respiratory distress syndrome. Thorax 2017;72.
27. Brown SM, Wilson E, Presson AP, et al. Predictors of 6-month health utility outcomes in survivors of acute respiratory distress syndrome. Thorax 2017;72:311-7.
28. L angfelder P, Luo R, Oldham MC, et al. Is my network module preserved, reproducible PLoS Comput Biol 2011;7:e1001057.
29. Breiman L, Friedman J, Olshen R, et al. Classification, regression trees. Belmont, CA: Wadsworth, 1984.
30. L angfelder P, Horvath S. WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics 2008;9:559.
31. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical, Powerful Approach to Multiple Testing. J R Stat Soc Series B 1995;57:289-300.
32. N eedham DM, Colantuoni E, Dinglas VD, et al. Rosuvastatin versus placebo for delirium in intensive care, subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: An ancillary study to a randomised controlled trial. Lancet Respir Med 2016;4:203-12.
33. Pickard AS, Neary MP, Cella D. Estimation of minimally important differences in EQ-5D utility, VAS scores in Cancer. Health Qual Life Outcomes 2007;5:70.
34. Samsa G, Edelman D, Rothman ML, et al. Determining clinically important differences in health status measures: A general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics 1999;15:141-55.
35. Hays RD, Morales LS. The RAND-36 measure of health-related quality of life. Ann Med 2001;33:350-7.
36. G ower JC. A General Coefficient of Similarity, some of its Properties. Biometrics 1971;27:857-71.
37. Presson AP, Sobel EM, Papp JC, et al. Integrated weighted gene co-expression network analysis with an application to chronic fatigue syndrome. BMC Syst Biol 2008;2:95.
38. Presson AP, Yoon NK, Bagryanova L, et al. Protein expression based multimarker analysis of breast Cancer samples. BMC Cancer 2011;11:230.
39. L evine AJ, Miller JA, Shapshak P, et al. Systems analysis of human brain gene expression: Mechanisms for HIV-associated neurocognitive impairment, common pathways with Alzheimer's disease. BMC Med Genomics 2013;6:4.
40. Walter SD, Eliasziw M, Donner A. Sample size, optimal designs for reliability studies. Stat Med 1998;17:101-10.
41. R Foundation for Statistical Computing. R: A language, environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2009.
42. Herridge MS, Chu LM, Matte A, et al. The RECOVER program: Disability risk groups, 1-Year outcome after 7 or more days of mechanical ventilation. Am J Respir Crit Care Med 2016;194:831-44.
43. Barnato AE, Albert SM, Angus DC, et al. Disability among elderly survivors of mechanical ventilation. Am J Respir Crit Care Med 2011;183:1037-42.
44. I washyna TJ, Netzer G, Langa KM, et al. Spurious inferences about long-term outcomes: The case of severe Sepsis, geriatric conditions. Am J Respir Crit Care Med 2012;185:835-41.
45. Oeyen SG, Benoit DD, Annemans L, et al. Long-term outcomes, quality of life in critically ill patients with hematological or solid malignancies: A single center study. Intensive Care Med 2013;39:889-98.
46. N isula S, Vaara ST, Kaukonen KM, et al. Six-month survival, quality of life of intensive care patients with acute kidney injury. Crit Care 2013;17:R250.
47. Hofhuis JG, Spronk PE, van Stel HF, et al. Quality of life before intensive care unit admission is a predictor of survival. Crit Care 2007;11:R78.
48. Pfoh ER, Wozniak AW, Colantuoni E, et al. Physical declines occurring after hospital discharge in ARDS survivors: A 5-year longitudinal study. Intensive Care Med 2016;42:1557-66.
49. Varadhan R, Weiss CO, Segal JB, et al. Evaluating health outcomes in the presence of competing risks: A review of statistical methods, clinical applications. Med Care 2010;48(6 Suppl):S96-105.
50. Pandharipande PP, Girard TD, Jackson JC, et al. Long-term cognitive impairment after critical illness. N Engl J Med 2013;369:1306-16.
51. Maley JH, Brewster I, Mayoral I, et al. Resilience in survivors of critical illness in the context of the survivors' Experience, recovery. Ann Am Thorac Soc 2016;13:1351-60.
52. R edekop WK, Mladsi D. The faces of personalized medicine: A framework for understanding its meaning, scope. Value Health 2013;16(6 Suppl):S4-S9.
53. President's Council of Advisors on Science, Technology. Priorities for Personalized Medicine. Washington, DC, 2008.
54. Herridge MS. The challenge of designing a post-critical illness rehabilitation intervention. Crit Care 2011;15:1002.
55. Hashem MD, Parker AM, Needham DM. Early mobilization, Rehabilitation of Patients who are critically Ill. Chest 2016;150:722-31.
56. Puthucheary ZA, Denehy L. Exercise interventions in critical illness survivors: Understanding Inclusion, Stratification Criteria. Am J Respir Crit Care Med 2015;191:1464-7.